Advertisement

The Macula pp 195-200 | Cite as

Long-term visual results after vitrectomy in diabetic macular edema

  • Gerhard Kieselbach
  • F. Kralinger
  • M. Pedri
  • J. Troger
  • M. T. Kralinger

Abstract

Since the introduction of lasercoagulation, therapy of diabetic macular edema, which is the most frequent cause for loss of vision in diabetic patients, had become possible. The accumulation of intraretinal fluid due to hyperpermeability of the retinal vasculature may lead to focal, diffuse and cystoid edema [1].

Keywords

Visual Acuity Macular Edema Diabetic Macular Edema Cystoid Macular Edema Posterior Vitreous Detachment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Klein R, Klein BE, Moss SE, et al (1984) The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology 91: 1464–74PubMedGoogle Scholar
  2. 2.
    Photocoagulation for diabetic macular edema (1985) Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. Arch Ophthalmol 103: 1796–806CrossRefGoogle Scholar
  3. 3.
    Bresnick GH (1986) Diabetic macular edema. A review. Ophthalmology 93: 989–97PubMedGoogle Scholar
  4. 4.
    Olk RJ (1986) Modified grid argon (blue-green) laser photocoagulation for diffuse diabetic macular edema. Ophthalmology 93: 938–50PubMedGoogle Scholar
  5. 5.
    Blankenship GW (1979) Diabetic macular edema and argon laser photocoagulation: a prospective randomized study. Ophthalmology 86: 69–78PubMedGoogle Scholar
  6. 6.
    Lewis H, Abrams GW, Blumenkranz MS, Campo RV (1992) Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 99: 753–9PubMedGoogle Scholar
  7. 7.
    Harbour JW, Smiddy WE, Flynn HW Jr, Rubsamen PE (1996) Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane. Am J Ophthalmol 121: 405–13PubMedGoogle Scholar
  8. 8.
    Ikeda T, Sato K, Katano T, Hayashi Y (2000) Improved visual acuity following pars plana vitrectomy for diabetic cystoid macular edema and detached posterior hyaloid. Retina 20: 220–2PubMedCrossRefGoogle Scholar
  9. 9.
    Tachi N, Ogino N (1996) Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am J Ophthalmol 122: 258–60PubMedGoogle Scholar
  10. 10.
    Gandorfer A, Messmer EM, Ulbig MW, Kampik A (2000) Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane. Retina 20: 126–33PubMedCrossRefGoogle Scholar
  11. 11.
    Pendergast SD, Hassan TS, Williams GA, et al (2000) Vitrectomy for diffuse diabetic macular edema associated with a taut premacular posterior hyaloid. Am J Ophthalmol 130: 178–86PubMedCrossRefGoogle Scholar
  12. 12.
    La Heij EC, Hendrikse F, Kessels AG, Derhaag PJ (2001) Vitrectomy results in diabetic macular oedema without evident vitreomacular traction. Graefes Arch Clin Exp Ophthalmol 239: 264–70PubMedCrossRefGoogle Scholar
  13. 13.
    Otani T, Kishi S (2002) A controlled study of vitrectomy for diabetic macular edema. Am J Ophthalmol 134: 214–9PubMedCrossRefGoogle Scholar
  14. 14.
    Yamamoto T, Akabane N, Takeuchi S (2001) Vitrectomy for diabetic macular edema: the role of posterior vitreous detachment and epimacular membrane. Am J Ophthalmol 132: 369–77PubMedCrossRefGoogle Scholar
  15. 15.
    Stefansson E (2001) The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology. Acta Ophthalmol Scand 79: 435–40PubMedCrossRefGoogle Scholar
  16. 16.
    Antonetti DA, Barber AJ, Khin S, et al (1998) Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes 47: 1953–9Google Scholar
  17. 17.
    Aiello LP, Bursell SE, Clermont A, et al (1997) Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes 46: 1473–80PubMedCrossRefGoogle Scholar
  18. 18.
    Gardner TW, Lesher T, Khin S, et al (1996) Histamine reduces ZO-1 tight-junction protein expression in cultured retinal microvascular endothelial cells. Biochem J 320 (Pt 3): 717–21PubMedGoogle Scholar
  19. 19.
    Dowler JG, Sehmi KS, Hykin PG, Hamilton AM (1999) The natural history of macular edema after cataract surgery in diabetes. Ophthalmology 106: 663–8PubMedCrossRefGoogle Scholar
  20. 20.
    Ikeda T, Sato K, Katano T, Hayashi Y (1999) Vitrectomy for cystoid macular oedema with attached posterior hyaloid membrane in patients with diabetes. Br J Ophthalmol 83: 12–14PubMedCrossRefGoogle Scholar
  21. 21.
    Wright PL, Wilkinson CP, Balyeat HD, et al (1988) Angiographic cystoid macular edema after posterior chamber lens implantation. Arch Ophthalmol 106: 740–4PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 2004

Authors and Affiliations

  • Gerhard Kieselbach
    • 1
  • F. Kralinger
    • 2
  • M. Pedri
    • 1
  • J. Troger
    • 1
  • M. T. Kralinger
    • 1
  1. 1.Ophthalmic ClinicUniversity InnsbruckAustria
  2. 2.Trauma Surgery ClinicUniversity InnsbruckAustria

Personalised recommendations